These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 15242524

  • 1. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y, Ye T, Sun D, Maynard J, Deisseroth A.
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [Abstract] [Full Text] [Related]

  • 2. Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.
    Liu Y, Ye T, Maynard J, Akbulut H, Deisseroth A.
    Cancer Gene Ther; 2006 Apr; 13(4):346-56. PubMed ID: 16179927
    [Abstract] [Full Text] [Related]

  • 3. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
    Liu Y, Deisseroth A.
    Cancer Gene Ther; 2006 Sep; 13(9):845-55. PubMed ID: 16710344
    [Abstract] [Full Text] [Related]

  • 4. Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma.
    Zhang L, Akbulut H, Tang Y, Peng X, Pizzorno G, Sapi E, Manegold S, Deisseroth A.
    Mol Ther; 2002 Sep; 6(3):386-93. PubMed ID: 12231175
    [Abstract] [Full Text] [Related]

  • 5. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
    Liu Y, Ye T, Sun D, Maynard J, Deisseroth A.
    Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
    [Abstract] [Full Text] [Related]

  • 6. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
    Wakayama M, Abei M, Kawashima R, Seo E, Fukuda K, Ugai H, Murata T, Tanaka N, Hyodo I, Hamada H, Yokoyama KK.
    Clin Cancer Res; 2007 May 15; 13(10):3043-50. PubMed ID: 17505007
    [Abstract] [Full Text] [Related]

  • 7. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY, Ahn M, Chung HC, Gardner TA, Kao C, Lee SJ, Kim SJ.
    Cancer Gene Ther; 2004 Aug 15; 11(8):532-8. PubMed ID: 15167900
    [Abstract] [Full Text] [Related]

  • 8. A novel attenuated replication-competent adenovirus for melanoma therapy.
    Peter I, Graf C, Dummer R, Schaffner W, Greber UF, Hemmi S.
    Gene Ther; 2003 Apr 15; 10(7):530-9. PubMed ID: 12646858
    [Abstract] [Full Text] [Related]

  • 9. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME, Beard BC, Lieber A, Kiem HP.
    Cancer Res; 2007 Sep 15; 67(18):8783-90. PubMed ID: 17875719
    [Abstract] [Full Text] [Related]

  • 10. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
    Nakamura T, Sato K, Hamada H.
    Hum Gene Ther; 2002 Mar 20; 13(5):613-26. PubMed ID: 11916485
    [Abstract] [Full Text] [Related]

  • 11. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
    Koizumi N, Mizuguchi H, Utoguchi N, Watanabe Y, Hayakawa T.
    J Gene Med; 2003 Apr 20; 5(4):267-76. PubMed ID: 12692861
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May 20; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y, Okada N, Mizuguchi H, Hayakawa T, Nakagawa S, Mayumi T.
    Cancer Gene Ther; 2005 Jul 20; 12(7):608-16. PubMed ID: 15746944
    [Abstract] [Full Text] [Related]

  • 14. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
    Fecker LF, Rückert S, Kurbanov BM, Schmude M, Stockfleth E, Fechner H, Eberle J.
    Hum Gene Ther; 2011 Apr 20; 22(4):405-17. PubMed ID: 20977303
    [Abstract] [Full Text] [Related]

  • 15. Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells.
    Rivera AA, Davydova J, Schierer S, Wang M, Krasnykh V, Yamamoto M, Curiel DT, Nettelbeck DM.
    Gene Ther; 2004 Dec 20; 11(23):1694-702. PubMed ID: 15496964
    [Abstract] [Full Text] [Related]

  • 16. Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro.
    Fontecedro AC, Lutschg V, Eichhoff O, Dummer R, Greber UF, Hemmi S.
    Virol J; 2010 Jul 29; 7():175. PubMed ID: 20670430
    [Abstract] [Full Text] [Related]

  • 17. Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures.
    Banerjee NS, Rivera AA, Wang M, Chow LT, Broker TR, Curiel DT, Nettelbeck DM.
    Mol Cancer Ther; 2004 Apr 29; 3(4):437-49. PubMed ID: 15078987
    [Abstract] [Full Text] [Related]

  • 18. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
    Nettelbeck DM, Rivera AA, Balagué C, Alemany R, Curiel DT.
    Cancer Res; 2002 Aug 15; 62(16):4663-70. PubMed ID: 12183423
    [Abstract] [Full Text] [Related]

  • 19. Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses.
    Schmitz M, Graf C, Gut T, Sirena D, Peter I, Dummer R, Greber UF, Hemmi S.
    Gene Ther; 2006 Jun 15; 13(11):893-905. PubMed ID: 16482201
    [Abstract] [Full Text] [Related]

  • 20. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M, Zhang X, Han Z, Chen X, Yang L, Sheng Y, Wen J.
    Oncol Rep; 2013 Feb 15; 29(2):798-804. PubMed ID: 23165979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.